Dr. Rajah Vijay Kumar, Chairman and Chief Scientific Officer of the Organization de Scalene and Scalene Cybernetics Ltd. in Bengaluru, has invented the Scalene Hypercharge Corona Canon (SHYCOCAN).

It is a powerful device that attacks and disables Coronavirus. SHYCOCAN is CE marked (EU- Class I) and has been cleared by US FDA under ‘Enforcement Policy for Sterilizers, Disinfectant Devices and Air Purifiers during the COVID 19 Public Health Emergency’.

This device will be manufactured and marketed in India by Eureka Forbes under the brand name FORBES CORONAGUARD (Powered by SHYCOCAN).  

Initiatives surrounding the R&D on the device prototype began in April 2019, to stem the decline in workforce productivity due to the common cold and seasonal Influenza in Scalene's facilities.

"This innovative technology is intended to 'physically attenuate' the homing mechanism on the virus and prevent infectivity. The device is designed to release trillions of environmentally safe electrons, applying well-known principles of physics, which disables the S protein in the Corona virus so that it cannot attach itself to human cells. The emanated electron cloud actively 'disarms' air and surface transmission of the Corona family of viruses. The CORONAGUARD does not use any chemicals nor does it produce ozone, or ionize the air to produce reactive oxygen species, oxides of nitrogen or other harmful compounds. The device can be safely deployed in all environments inhabited by people, be it very large or small enclosed spaces”, said  Dr. Rajah Vijay Kumar.

Announcing it to the media, Marzin R. Shroff, CEO & Managing Director Eureka Forbes said, “For over 38 years, we at Eureka Forbes have been protecting Indians against harmful viruses and bacteria in water, air and surfaces. We are privileged to be working together with Dr. Rajah Vijay Kumar in bringing Forbes Coronaguard to India. It is a device that offers real time protection against infection from the Coronavirus within closed spaces. Our vision is to contain the spread of this disease and to make a positive difference to the lives of millions of Indians first, and then to the rest of the world.”

"While we go through the final ratifications and necessary approvals, the commercial production of CoronaGuard is expected by August end/early September 2020. We are looking at a launch and pre-bookings that should open in Mid-August” said Mr. Shroff.